PL1866328T3 - Peptydy zwiększające wytwarzanie kolagenu lub kwasu hialuronowego - Google Patents

Peptydy zwiększające wytwarzanie kolagenu lub kwasu hialuronowego

Info

Publication number
PL1866328T3
PL1866328T3 PL06729849T PL06729849T PL1866328T3 PL 1866328 T3 PL1866328 T3 PL 1866328T3 PL 06729849 T PL06729849 T PL 06729849T PL 06729849 T PL06729849 T PL 06729849T PL 1866328 T3 PL1866328 T3 PL 1866328T3
Authority
PL
Poland
Prior art keywords
peptides
hyaluronic acid
acid production
increase collagen
collagen
Prior art date
Application number
PL06729849T
Other languages
English (en)
Inventor
Yoichi Honma
Kazuaki Kikuchi
Hiroshi Uemura
Satoshi Inaoka
Shuichi Tsunetsugu
Original Assignee
Rohto Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharma filed Critical Rohto Pharma
Publication of PL1866328T3 publication Critical patent/PL1866328T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
PL06729849T 2005-03-22 2006-03-17 Peptydy zwiększające wytwarzanie kolagenu lub kwasu hialuronowego PL1866328T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005081899 2005-03-22
JP2005308356 2005-10-24
EP06729849A EP1866328B1 (en) 2005-03-22 2006-03-17 Peptides which increase collagen or hyaluronic acid production
PCT/JP2006/305901 WO2006101187A1 (en) 2005-03-22 2006-03-17 Peptides that increase collagen or hyaluronic acid production

Publications (1)

Publication Number Publication Date
PL1866328T3 true PL1866328T3 (pl) 2011-05-31

Family

ID=36572038

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06729849T PL1866328T3 (pl) 2005-03-22 2006-03-17 Peptydy zwiększające wytwarzanie kolagenu lub kwasu hialuronowego

Country Status (7)

Country Link
US (1) US7989590B2 (pl)
EP (1) EP1866328B1 (pl)
KR (1) KR101314899B1 (pl)
DE (1) DE602006019567D1 (pl)
HK (1) HK1116498A1 (pl)
PL (1) PL1866328T3 (pl)
WO (1) WO2006101187A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4950571B2 (ja) * 2006-06-23 2012-06-13 ロート製薬株式会社 コラーゲン産生促進能を有する組成物
WO2007148804A1 (ja) * 2006-06-23 2007-12-27 Rohto Pharmaceutical Co., Ltd. ヒアルロン酸産生促進能を有する組成物
JP2008074788A (ja) * 2006-09-22 2008-04-03 Rohto Pharmaceut Co Ltd エラスチン産生促進剤
WO2010071132A1 (ja) 2008-12-15 2010-06-24 カルピス株式会社 皮膚老化抑制ペプチド
KR101667383B1 (ko) * 2012-03-28 2016-10-18 주식회사 인코스팜 비오틴이 결합된 ｈｅｘａｐｅｐｔｉｄｅ-２ 유도체 및 이의 용도
WO2019216651A1 (ko) * 2018-05-08 2019-11-14 경상대학교산학협력단 주름개선 효능을 갖는 펩티드
KR102543595B1 (ko) * 2022-02-21 2023-06-21 경북대학교 산학협력단 아미드화 아미노산을 포함하는 콜라겐 생성 촉진용 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270447A (en) * 1988-05-20 1993-12-14 The United States Of America As Represented By The Department Of Health & Human Services Metalloproteinase peptides: role in diagnosis and therapy
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
US5516891A (en) * 1992-06-16 1996-05-14 Kinerton, Ltd. Liquid phase synthesis of peptides and peptide derivatives
JP3159419B2 (ja) 1993-12-28 2001-04-23 カネボウ株式会社 化粧料
JPH09176036A (ja) 1995-12-27 1997-07-08 Lion Corp 生体ヒアルロン酸合成促進剤
US6126939A (en) 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
AU6887096A (en) * 1996-09-11 1998-04-02 Patrick T. Prendergast Immune direction therapy
JPH10182402A (ja) 1996-12-25 1998-07-07 Nagase & Co Ltd ヒアルロン酸合成促進剤
JP2000136147A (ja) 1998-10-29 2000-05-16 Lion Corp 生体ヒアルロン酸合成促進剤
US6610836B1 (en) * 1999-01-29 2003-08-26 Genome Therapeutics Corporation Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
AU3194900A (en) 1999-03-19 2000-10-09 Yamanouchi Pharmaceutical Co., Ltd. Method for screening cysteine protease inhibitor
EP1093804A1 (en) 1999-10-19 2001-04-25 Beiersdorf Aktiengesellschaft Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin
JP3696464B2 (ja) 2000-01-25 2005-09-21 株式会社カネボウ化粧品 コラーゲン合成促進剤及びコラーゲン代謝賦活剤
AU2001297591A1 (en) 2000-11-01 2002-09-19 Zengen, Inc. A sunburn treatment and sunburn prevention method
US20040214184A1 (en) * 2001-02-28 2004-10-28 Skubitz Keith M Small peptides capable of modulating the function of cd66 (ceacam) family members
WO2005090387A2 (en) 2004-03-23 2005-09-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Histone h2a peptide derivatives and analogs and methods of use thereof
IL145181A0 (en) 2001-08-29 2009-02-11 Uri Wormser Protective factors against burns and noxious stimuli
ATE519115T1 (de) * 2002-06-13 2011-08-15 Merck Patent Gmbh Verfahren für die identifizierung von allo- antigenen und ihre verwendung für krebstherapie und transplantation
JP4544500B2 (ja) 2002-07-19 2010-09-15 一丸ファルコス株式会社 ヒアルロン酸合成促進剤
JP5376747B2 (ja) 2002-10-02 2013-12-25 カタリスト バイオサイエンシーズ， インコーポレイテッド 改変された特異性を有するプロテアーゼを作製する方法およびスクリーニングする方法
US20060040870A1 (en) * 2004-05-28 2006-02-23 Lebien Tucker W Enhancement of apoptosis by caspase-9 inhibitors

Also Published As

Publication number Publication date
KR101314899B1 (ko) 2013-10-04
HK1116498A1 (en) 2008-12-24
EP1866328A1 (en) 2007-12-19
US20090209728A1 (en) 2009-08-20
WO2006101187A1 (en) 2006-09-28
DE602006019567D1 (de) 2011-02-24
EP1866328B1 (en) 2011-01-12
KR20070114151A (ko) 2007-11-29
US7989590B2 (en) 2011-08-02

Similar Documents

Publication Publication Date Title
EP1961772A4 (en) CATIONIZED HYALURONIC ACID
GB2425620B (en) Production system
EP1953191A4 (en) polylactic acid
GB2429993B (en) Production system
HUE056793T2 (hu) Injektálható hialuronsav-gél
GB0602125D0 (en) Sensitizer-incorporated biomaterials
EP2117620A4 (en) PROTOELASTINE BIOMATERIALS FROM TROOELASTINE
HK1116498A1 (en) Peptides which increase collagen or hyaluronic acid production
IL172037A0 (en) Letrozole production process
GB0500604D0 (en) Novel process
EP1956045A4 (en) polylactic acid
EP1932909A4 (en) VEGETABLE PRODUCING HYALURONIC ACID
GB0519758D0 (en) Novel process
GB0526347D0 (en) Defatting collagen
GB2432583B (en) Letrozole production process
GB0526474D0 (en) Novel process
ZA200801497B (en) Methionine producing recombinant microorganisms
EP2314681A4 (en) MODIFIED BIOTIN BINDING PROTEIN
GB0526019D0 (en) Peptides
GB0516527D0 (en) Peptides
EP1939286A4 (en) NEW PEPTIDE
EP2037968A4 (en) BIOCOMPATIBLE HYDROGELS
EP2097439A4 (en) NEW PEPTIDE
IL197675A0 (en) Peptides
EP1971202A4 (en) SERUM PRODUCTION SYSTEM